B. Vogelstein and K. Kinzler, Cancer genes and the pathways they control, Nature Medicine, vol.1, issue.8, pp.789-99, 2004.
DOI : 10.1038/sj.onc.1207130

P. Laurent-puig and J. Zucman-rossi, Genetics of hepatocellular tumors, Oncogene, vol.54, issue.27, pp.3778-86, 2006.
DOI : 10.1002/hep.21068

S. Forbes, G. Bhamra, and S. Bamford, The Catalogue of Somatic Mutations in Cancer (COSMIC), Curr Protoc Hum Genet, vol.274, issue.1, 2008.
DOI : 10.1002/0471142905.hg1011s57

O. Bluteau, E. Jeannot, and P. Bioulac-sage, Bi-allelic inactivation of TCF1 in hepatic adenomas, Nature Genetics, vol.120, issue.2, pp.312-317, 2002.
DOI : 10.1038/35057062

S. Rebouissou, M. Amessou, and G. Couchy, Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours, Nature, vol.31, issue.7226, pp.200-204, 2009.
DOI : 10.1038/nature07475

URL : https://hal.archives-ouvertes.fr/inserm-00340859

Y. Bacq, E. Jacquemin, and C. Balabaud, Familia liver adenomatosis associated with hepatocyte nuclear factor 1?? inactivation1 1The authors thank Leigh Pascoe for critical reading of the manuscript, H??l??ne Blanch?? and Hung Bui of the CEPH/Fondation Jean Dausset for technical help in sequencing, and Drs. A. Saillant, E. Akodjenou, and E. Urvoas (Pediatric and Radiology Units, H??pitaux de Chartres, France) for referring patient B1 to E.J. and for performing liver ultrasound screening in family B., Gastroenterology, vol.125, issue.5, pp.1470-1475, 2003.
DOI : 10.1016/j.gastro.2003.07.012

J. Lee, I. Chu, and J. Heo, Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling, Hepatology, vol.3, issue.3, pp.667-76, 2004.
DOI : 10.1002/hep.20375

J. Lee, J. Heo, and L. Libbrecht, A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells, Nature Medicine, vol.149, issue.4, pp.410-416, 2006.
DOI : 10.1111/j.1349-7006.2003.tb01366.x

A. Villanueva, P. Newell, D. Chiang, S. Friedman, J. Llovet et al., Genomics and signaling pathways in hepatocellular carcinoma Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas, Semin Liver Dis Proc Natl Acad Sci U S A, vol.2795, issue.10, pp.55-768847, 1998.

Y. Miyoshi, K. Iwao, and Y. Nagasawa, Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3 Nagafuchi A, Takeichi M. Transmembrane control of cadherin-mediated cell adhesion: a 94 kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin, Cancer Res Cell Regul, vol.581, issue.12, pp.2524-737, 1989.

A. Micsenyi, X. Tan, T. Sneddon, J. Luo, G. Michalopoulos et al., ??-Catenin is temporally regulated during normal liver development???, Gastroenterology, vol.126, issue.4, pp.1134-1180, 2004.
DOI : 10.1053/j.gastro.2003.12.047

S. Benhamouche, T. Decaens, and C. Godard, Apc Tumor Suppressor Gene Is the ???Zonation-Keeper??? of Mouse Liver, Developmental Cell, vol.10, issue.6, pp.759-70, 2006.
DOI : 10.1016/j.devcel.2006.03.015

A. Cadoret, C. Ovejero, and B. Terris, New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration Conditional deletion of beta-catenin reveals its role in liver growth and regeneration, Oncogene Hepatology Gastroenterology, vol.2133131, issue.19, pp.8293-3011098, 2001.

P. Laurent-puig, P. Legoix, and O. Bluteau, Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity, Gastroenterology Oncogene, vol.12018, issue.22, pp.1763-734044, 1999.

V. Audard, G. Grimber, and C. Elie, Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma, J Pathol Hepatology Hepatogastroenterology, vol.2124951, issue.24, pp.345-52821, 2004.

H. Hsu, Y. Jeng, T. Mao, J. Chu, P. Lai et al., Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa, pp.763-70429, 1991.

I. Hsu, R. Metcalf, T. Sun, J. Welsh, N. Wang et al., Mutational hotspot in the p53 gene in human hepatocellular carcinomas Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia, al. Frequent mutations of hepatocyte nuclear factor 1 in colorectal cancer with microsatellite instability, pp.427-81225, 1991.

S. Rebouissou, C. Rosty, and F. Lecuru, Mutation of TCF1 encoding hepatocyte nuclear factor 1?? in gynecological cancer, Oncogene, vol.23, issue.45, pp.7588-92, 2004.
DOI : 10.1038/sj.onc.1207989

S. Rebouissou, V. Vasiliu, and C. Thomas, Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas Bioulac Hepatocellular adenoma management and phenotypic classification: The bordeaux experience. Hepatology Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets, Yakicier Y, Legoix P, Vaury C, et al. Identification of homozygous deletions at chromosome 16q23 in Aflatoxin B1 exposed hepatocellular carcinoma, pp.603-14855, 2001.

X. Chen, S. Cheung, and S. So, Gene Expression Patterns in Human Liver Cancers, Molecular Biology of the Cell, vol.13, issue.6, pp.1929-1968, 2002.
DOI : 10.1091/mbc.02-02-0023

K. Breuhahn, S. Vreden, and R. Haddad, Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II Overexpression, Cancer Research, vol.64, issue.17, pp.6058-64, 2004.
DOI : 10.1158/0008-5472.CAN-04-0292

P. Kaposi-novak, J. Lee, L. Gomez-quiroz, C. Coulouarn, V. Factor et al., Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype, Journal of Clinical Investigation, vol.116, issue.6, pp.1582-95, 2006.
DOI : 10.1172/JCI27236DS1

D. Chiang, A. Villanueva, and Y. Hoshida, Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma, Cancer Research, vol.68, issue.16, pp.6779-88, 2008.
DOI : 10.1158/0008-5472.CAN-08-0742

C. Coulouarn, V. Factor, and S. Thorgeirsson, Transforming growth factor-?? gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer, Hepatology, vol.24, issue.2, pp.2059-67, 2008.
DOI : 10.1002/hep.22283

T. Yamashita, M. Forgues, and W. Wang, EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Gene expression in fixed tissues and outcome in hepatocellular carcinoma Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma, Cancer Res N Engl J Med Cancer Res, vol.6835969, issue.45, pp.1451-611995, 2008.

B. Cullen, Y. Ladeiro, G. Couchy, and C. Balabaud, Transcription and processing of human microRNA precursors MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations, Mol Cell Hepatology, vol.1647, pp.861-866, 2004.

Y. Murakami, T. Yasuda, and K. Saigo, Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues, Oncogene, vol.13, issue.17, pp.2537-2582, 2006.
DOI : 10.1038/sj.onc.1209283

H. Kutay, S. Bai, and J. Datta, Downregulation of miR-122 in the rodent and human hepatocellular carcinomas, Journal of Cellular Biochemistry, vol.24, issue.3, pp.671-679, 2006.
DOI : 10.1002/jcb.20982

F. Meng, R. Henson, H. Wehbe-janek, K. Ghoshal, S. Jacob et al., MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer, Gastroenterology, vol.133, issue.2, pp.647-58, 2007.
DOI : 10.1053/j.gastro.2007.05.022

L. Gramantieri, M. Ferracin, and F. Fornari, Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma, Cancer Research, vol.67, issue.13, pp.6092-6101, 2007.
DOI : 10.1158/0008-5472.CAN-06-4607

Y. Huang, Y. Dai, and X. Yu, Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis, Journal of Gastroenterology and Hepatology, vol.38, issue.Suppl., pp.87-94, 2008.
DOI : 10.1111/j.1440-1746.2007.05223.x

Y. Wang, A. Lee, and J. Ma, Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target, Journal of Biological Chemistry, vol.283, issue.19, pp.13205-13220, 2008.
DOI : 10.1074/jbc.M707629200

J. Jiang, Y. Gusev, and I. Aderca, Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival, Clinical Cancer Research, vol.14, issue.2, pp.419-446, 2008.
DOI : 10.1158/1078-0432.CCR-07-0523

H. Varnholt, U. Drebber, and F. Schulze, MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma, Hepatology, vol.16, issue.4, pp.1223-1255, 2008.
DOI : 10.1002/hep.22158

H. Jia and M. Forgues, polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype Identification of metastasis-related microRNAs in hepatocellular carcinoma, Am J Pathol Hepatology, vol.17347, pp.856-64897, 2008.

J. Ji, J. Shi, and A. Budhu, MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer, New England Journal of Medicine, vol.361, issue.15, pp.1437-1484, 2009.
DOI : 10.1056/NEJMoa0901282

J. Ji, T. Yamashita, and A. Budhu, Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma, Hepatology Hepatology, vol.5049, issue.60, pp.472-801098, 2009.

X. Huang, Q. Wang, and J. Chen, Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated, Hepatology Research, vol.451, issue.3, pp.786-94, 2009.
DOI : 10.1111/j.1872-034X.2009.00502.x

H. Su, J. Yang, and T. Xu, MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity Loss of miR- 122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties, Cancer Res Oncogene, vol.6928, issue.63, pp.1135-423526, 2009.

H. Huang, H. Fujii, and A. Sankila, ??-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection, The American Journal of Pathology, vol.155, issue.6, pp.1795-801, 1999.
DOI : 10.1016/S0002-9440(10)65496-X

K. Taniguchi, L. Roberts, and I. Aderca, Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance, MF. Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas, pp.4863-716583, 1992.

M. Leon, M. Kew, S. Takada, K. Koike, S. Hirohashi et al., Analysis of ras gene mutations in hepatocellular carcinoma in southern African blacks Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of the tumor cells Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma, Anticancer Res Oncogene Jpn J Cancer Res, vol.15480, issue.70, pp.859-61189, 1989.

J. Lee, Y. Soung, and S. Kim, INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients, Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas, pp.16982-91477, 1999.

D. Yang, W. Huang, and J. Cui, The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma, Hepatobiliary Pancreat Dis Int, vol.3, pp.86-95, 2004.

H. Hayashi, K. Sugio, T. Matsumata, E. Adachi, K. Takenaka et al., The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan, Hepatology, vol.22, issue.6, pp.1702-1709, 1995.
DOI : 10.1016/0270-9139(95)90194-9

K. Honda, E. Sbisa, and A. Tullo, p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation, British Journal of Cancer, vol.77, issue.5, pp.776-82, 1998.
DOI : 10.1038/bjc.1998.126

S. Hussain, J. Schwank, F. Staib, X. Wang, and C. Harris, TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer, Oncogene, vol.55, issue.15, pp.2166-76, 2007.
DOI : 10.1016/j.gastro.2004.09.018

T. Chen, L. Hsieh, and T. Kuo, p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma Infrequent alterations of the p16INK4A gene in liver cancer, High frequency of p16INK4A gene alterations in hepatocellular carcinoma, pp.1621-6176, 1996.

Y. Ishizaki, S. Ikeda, and M. Fujimori, Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas, Int J Oncol, vol.24, pp.1077-83, 2004.

Y. Kim, C. Park, and H. Kim, Genetic alterations of Wnt signaling pathwayassociated genes in hepatocellular carcinoma Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1, J Gastroenterol Hepatol Liver Int Nat Genet Oncogene, vol.23252426, issue.87, pp.110-870, 2000.

X. Zhang, H. Xu, and Y. Murakami, Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma, Cancer Res, vol.54, pp.4177-82, 1994.

S. Kawate, S. Takenoshita, and S. Ohwada, Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma., International Journal of Oncology, vol.14, pp.127-158, 1999.
DOI : 10.3892/ijo.14.1.127

M. Yakicier, M. Irmak, A. Romano, M. Kew, and M. Ozturk, Smad2 and Smad4 gene mutations in hepatocellular carcinoma, Oncogene, vol.18, issue.34, pp.4879-83, 1999.
DOI : 10.1038/sj.onc.1202866

J. Bae, J. Rho, and T. Lee, Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors, 94. Yao YJ, Ping XL, Zhang H, et al. PTEN/MMAC1 mutations in hepatocellular carcinomas, pp.1007-13287, 1999.

D. Souza, A. Hankins, G. Washington, M. Orton, T. Jirtle et al., M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity, Nature Genetics, vol.15, issue.4, pp.447-456, 1995.
DOI : 10.1006/bbrc.1993.2542

Y. Oka, R. Waterland, and J. Killian, M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis, Hepatology Proc Natl Acad Sci U S A Eur J Cancer, vol.359440, issue.97, pp.1153-6310351, 1997.

E. Jeannot, K. Poussin, and L. Chiche, Association of CYP1B1 Germ Line Mutations with Hepatocyte Nuclear Factor 1??-Mutated Hepatocellular Adenoma, Cancer Research, vol.67, issue.6, pp.2611-2617, 2007.
DOI : 10.1158/0008-5472.CAN-06-3947

URL : https://hal.archives-ouvertes.fr/inserm-00138277

E. Jeannot, D. Wendum, and F. Paye, Hepatocellular adenoma displaying a HNF1?? inactivation in a patient with familial adenomatous polyposis coli, Journal of Hepatology, vol.45, issue.6, pp.883-889, 2006.
DOI : 10.1016/j.jhep.2006.06.020

URL : https://hal.archives-ouvertes.fr/inserm-00130312

L. Pelletier, S. Rebouissou, and A. Paris, Loss of hepatocyte nuclear factor 1?? function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis, Hepatology, vol.15, issue.2, pp.557-66, 2010.
DOI : 10.1002/hep.23362

URL : https://hal.archives-ouvertes.fr/hal-01173782

S. Rebouissou, S. Imbeaud, and C. Balabaud, HNF1?? Inactivation Promotes Lipogenesis in Human Hepatocellular Adenoma Independently of SREBP-1 and Carbohydrate-response Element-binding Protein (ChREBP) Activation, Journal of Biological Chemistry, vol.282, issue.19, pp.14437-14483, 2007.
DOI : 10.1074/jbc.M610725200

URL : https://hal.archives-ouvertes.fr/inserm-00138278

Y. Reznik, T. Dao, and R. Coutant, Hepatocyte Nuclear Factor-1?? Gene Inactivation: Cosegregation between Liver Adenomatosis and Diabetes Phenotypes in Two Maturity-Onset Diabetes of the Young (MODY)3 Families, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.3, pp.1476-80, 2004.
DOI : 10.1210/jc.2003-031552

P. Bioulac-sage, S. Rebouissou, and C. Thomas, Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry, Hepatology, vol.25, issue.3, pp.740-748, 2007.
DOI : 10.1002/hep.21743